Surrounded by advocates and parents who had lost children to overdoses, Gov Susana Martinez signed legislation that was approved unanimously by lawmakers during their recent session. The former prosecutor and two-term Republican governor said she has seen firsthand what drug abuse can do to families and communities.
"We're making progress but it's never enough," she said. "We have to keep working hard at this problem and reducing the number of overdoses. Signing this bill is an important step to fight the scourge of drug abuse and overdose fatalities."
The state was the first in 2001 to increase access to the overdose-reversal drug naloxone and a few years later it led the way to release people from legal liability when they assist in overdose situations.
New Mexico also was the first state to allow pharmacists to dispense naloxone without a prescription in an effort to expand access to the life-saving drug.
Other measures enacted by New Mexico in recent years include requiring all licensed clinicians to undergo extra training for prescribing painkillers and the creation of a system to track prescriptions for pain medication so addicts cannot obtain new prescriptions from unsuspecting doctors.
In 2014, New Mexico had one of the highest overdose death rates in the nation, second only to West Virginia. More recent health statistics show the state is now ranked 44th.
According to the Centers for Disease Control and Prevention, opioids were involved in more than 33,000 deaths nationally in 2015.
"This doesn't discriminate," said state Rep Sarah Maestas Barnes, the Albuquerque Republican who sponsored the legislation with Democratic colleagues.
"Every community, every county, every ethnicity, every socio-economic status, everybody is affected by this epidemic and that's why this bill is critically important," she said after the signing ceremony.
Joanna Katzman, a neurologist and director of the University of New Mexico Pain Center, was instrumental in helping craft the legislation after years of working on the problem.
She said expanding access to anti-overdose medication saves lives and increases recovery opportunities for addicts.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
